Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Directorate Change

16 Sep 2013 07:03

RNS Number : 0218O
Plant Health Care PLC
16 September 2013
 



Plant Health Care PLC

 

16 September 2013

 

PLANT HEALTH CARE PLC

 

("Plant Health Care" or "the Company")

 

Directorship Changes

 

Plant Health Care appoints Dr Richard Webb as non-executive director

 

Resignation of John Brady and release from obligation to exercise options

 

The Board of Plant Health Care is pleased to announce the appointment ofRichard Webb as a non-executive director.

 

Dr Webb, age 54, has previously been engaged by the Group as a consultant, and was instrumental in the development of its new business strategy and its current research and development strategy.

 

Dr Webb is Director of StepOut Ltd, a consultancy business he founded in 1995. Prior to that, he held various posts in the former ICI, including a period managing laboratory discovery and field development programmes for its public health business. He has had particularly broad exposure to the international agrochemical industry, which he has advised across a full spectrum of activities, from research targeting to post-patent brand management.

 

Dr Webb has a personal holding of 10,000 shares in the Company (representing 0.01% of the current issued share capital).

 

Dr Christopher Richards, Chairman, commented: "Richard Webb brings many years of strategic and innovation consulting experience to the Company and will specifically reinforce the science discussions at the Board."

 

Save for the information disclosed above, there is no other information to be disclosed under Rule 17 or Schedule Two, paragraph (g) of the AIM Rules for Companies in relation to Dr Richard Hannam Webb's appointment as a Director of the Company, other than as follows:

 

Current Directorships Past Directorships:

 

StepOut Ltd None

 

Investors in Innovation Ltd

 

Resignation of John Brady and release from obligation to exercise options

 

Further to an announcement made on 15 July 2013, the Company confirms that Mr John Brady, whose resignation as a director is effective as of today, shall be released from his obligation to exercise his options over 975,000 ordinary shares in the Company in two tranches on 15 October 2013 and13 November 2013.

 

For further information please contact:

 

Plant Health Care plc

Dr Christopher Richards, Chairman

Tel: +44 (0) 20 7250 1446

Paul Schmidt, Chief Executive Officer

Tel: +1-412-826-5488

 

Nomura Code Securities

Dr Christopher Golden / Juliet Thompson

Tel: +44 (0) 20 7776 1200

 

Powerscourt

Nick Dibden / Sophie Moate

 

Tel: +44 (0)20 7250 1446

nick.dibden@powerscourt-group.com

sophie.moate@powerscourt-group.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOABELLFXKFEBBB
Date   Source Headline
27th Jan 20214:41 pmRNSSecond Price Monitoring Extn
27th Jan 20214:36 pmRNSPrice Monitoring Extension
25th Jan 20217:00 amRNSTrading Statement
11th Jan 20217:00 amRNSNotice of Trading Statement/Investor Presentation
5th Jan 20213:37 pmRNSBrazil approves PHC279 to Control Soybean Rust
11th Dec 20207:00 amRNSInvestor Presentation
9th Nov 20207:00 amRNSPlant Health Care and Wilbur-Ellis sign Agreement
7th Oct 20207:00 amRNSGrant of Options
6th Oct 20207:00 amRNSNew US PREtec Patents Issued
2nd Oct 20205:48 pmRNSSignificant Shareholder
25th Sep 20207:00 amRNSInvestor Presentation
23rd Sep 20207:00 amRNSInvestor Presentation
15th Sep 20207:00 amRNSInterim Report 30 June 2020
29th Jul 20207:00 amRNSTrading Statement
26th Jun 20204:41 pmRNSSecond Price Monitoring Extn
26th Jun 20204:36 pmRNSPrice Monitoring Extension
25th Jun 20207:00 amRNSGrant of Options
18th Jun 20204:41 pmRNSSecond Price Monitoring Extn
18th Jun 20204:36 pmRNSPrice Monitoring Extension
16th Jun 20207:00 amRNSPHC398 Approved by US EPA: PHC279 submitted to EPA
9th Jun 20207:00 amRNSGrant of options
2nd Jun 202011:13 amRNSResult of AGM
29th May 20207:00 amRNSHolding(s) in Company
27th May 20207:00 amRNSUpdate on PHC279 2019 Field Trials
6th May 20205:12 pmRNSAnnual Report & Accounts and AGM Notice Published
1st May 20203:21 pmRNSDirector/PDMR Shareholding
24th Apr 20207:00 amRNSResults for the year ended 31 December 2019
25th Mar 20207:00 amRNSHolding(s) in Company
23rd Mar 20203:45 pmRNSHolding(s) in Company
19th Mar 20203:09 pmRNSHolding(s) in Company
16th Mar 202011:53 amRNSResults of General Meeting
11th Mar 20207:00 amRNSPHC279 Submitted for Regulatory Approval in Brazil
24th Feb 20209:18 amRNSResults of Placing and Subscription
24th Feb 20207:00 amRNSProposed Placing and Subscription
19th Feb 20207:00 amRNSBlock listing Interim Review
5th Feb 20207:00 amRNSEmploy California Registration
23rd Jan 20207:00 amRNSFirst US patent issues for PREtec peptide products
9th Jan 20207:00 amRNSBrazil Update
20th Dec 20197:00 amRNSHolding(s) in Company
19th Dec 20197:00 amRNSTrading Update
3rd Dec 20196:35 pmRNSHolding(s) in Company
22nd Nov 20192:11 pmRNSHolding(s) in Company
15th Nov 20193:42 pmRNSHolding(s) in Company
15th Nov 20193:36 pmRNSHolding(s) in Company
14th Nov 20193:36 pmRNSHolding(s) in Company
14th Nov 20197:00 amRNSHolding(s) in Company
13th Nov 20194:40 pmRNSHolding(s) in Company
13th Nov 20194:08 pmRNSHolding(s) in Company
13th Nov 20193:59 pmRNSHolding(s) in Company
13th Nov 20193:42 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.